Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California



 

Recent News and Articles on the Keywords: alzheimers + alzheimer + 34,700  Related to the article below (Last Update: 8/5/2008)

Exercise versus Alzheimer's
Chicago Tribune, United States -
A recent example is the idea that physical exercise can hold off Alzheimer's disease or slow the progression of symptoms in people who have been diagnosed. ...
Surprising Things That Affect Memory Forbes
Maternal link to Alzheimer's suggested United Press International
all 5 news articles »

RTE.ie
A Second Chance to Buy Wyeth?
Barron's - Aug 3, 2008
WYETH AND ITS IRISH PARTNER, ELAN, TUESDAY UNVEILED EAGERLY awaited details of a Phase II clinical trial of a promising Alzheimer's drug, bapineuzumab. ...
Speed Raisies Risks for Alzheimer?s Research Wall Street Journal Blogs
Alzheimer's Drugs: Investors' Impatience BusinessWeek
Wyeth, Elan Fall on Doubts Raised by Alzheimer's Test (Update1) Bloomberg
CNNMoney.com - MarketWatch
all 299 news articles »  ELN - PINK:ELNCF - WYE

Salem-News.Com
Alzheimer's Patient Missing In Salem
KPTV.com, OR - 57 minutes ago
Marion County deputies are asking for help in finding an Alzheimer's patient missing from an assisted living center in Salem. William Mefford, 68, was last ...
Search for missing alzheimer's patient in Salem KPOJ
Marion County police look for missing Alzheimer's patient KTVZ
Alzheimer's patient reported missing Statesman Journal
The Oregonian - OregonLive.com
all 10 news articles »

NECN
Scots Create Drug to Halt Alzheimer's Pill is 'Biggest ...
RedOrbit, TX -
SCOTS scientists have developed a drug they say can halt the devastating progress of Alzheimer's disease. It could prove at least twice as effective in ...
Alzheimer drug puts TauRx on biotech map Times Online
Alzheimer's brings heartache to millions but a breakthrough by a ... Scotsman
Alzheimer's disease researchers see progress on new drugs EiTB
McKnight's Long Term Care News - Dallas Morning News
all 49 news articles »
Alzheimer drug slows cognitive decline
Irish Times, Ireland -
A NEW DRUG has slowed cognitive decline by up to 81 per cent in Alzheimer patients during early pharmaceutical trials, it has been announced. ...
Nymox Has Global Patent Rights For Statin Drugs For The Treatment ... Medical News Today (press release)
all 2 news articles »  NYMX

Daily Mail
Blood pressure drugs can 'dramatically cut the risk of Alzheimer's ...
Daily Mail, UK - Jul 27, 2008
The effect was 'striking', cutting the risk of developing Alzheimer's by more than a third, according to a US study. Researchers looked at angiotensin ...
Health problems, personality raise Alzheimer's risk, studies show Dallas Morning News
New drug boosts brain function in Alzheimer's patients ABC Online
Update from the Alzheimer's international conference Los Angeles Times
U.S. News & World Report - Science Daily (press release)
all 678 news articles »

ChattahBox
Marriage: the midlife link to Alzheimer?s
malehealth, UK - Aug 4, 2008
Rebecca Wood, Chief Executive of the Alzheimer?s Research Trust, said: 'These findings are particularly worrying for the UK: a society with a high divorce ...
People Who Are Single Are More Likely To Develop Alzheimer?s ChattahBox
Being Single Linked To Increased Risk Of Alzheimer?s dBTechno
Singletons have greater Alzheimer's risk, study says CTV.ca
Chicago Sun-Times - Los Angeles Times
all 111 news articles »
Does aluminum cause Alzheimer's or breast cancer?
Bradenton Herald,  United States -
I have also read that aluminum may be associated with Alzheimer's disease. Every antiperspirant I have checked has aluminum as its main ingredient, ...
Scarsdale police still searching for missing Alzheimer's sufferer, 93
Lower Hudson Journal news, NY -
By Leslie Korngold SCARSDALE - A 93-year-old man with Alzheimer's disease who wandered off from his apartment on Saturday remains missing this morning, ...
Alzheimer's drug trial at OHSU shows promise in some patients
Media Newswire (press release), NY -
A drug designed to remove amyloid plaques from the brain appears to help some patients with mild to moderate Alzheimer's disease, according to a clinical ...
Source: Google News

[PDF] Glutamate receptors modulate oxidative stress in neuronal cells. A mini-review -
A Boldyrev, E Bulygina, A Makhro - Neurotox Res, 2004 - fpgrahamco.com
... II receptors may also lead to abnormal protein phosphorylation (ie, tau phos-
phorylation), culminating in neurodegenerative dis- orders (ie, Alzheimer disease ...

Book Review -
C Heron, C Everingham, S Stevens, L Shipgood, K … - International Journal of Language & Communication Disorders, 1995 - informaworld.com
... ISBN 0-412-34700-8. ... with language pathology in Alzheimer?s and non-Alzheimer dementias,
dis- cusses service provision and present and future speech and ...

Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-(2- … -
H Sugimoto, Y Tsuchiya, H Sugumi, K Higurashi, N … - Journal of Medicinal Chemistry, 1992 - pubs.acs.org
... showed a definite selectivity to AChE over the BuChE (about 34700-fold) and, at ...
dysfunctions have been identified in senile dementia of the Alzheimer?s type ...

[PDF] NHANES 1999-2000 Data Release -
PM Subsection, SP Questionnaire - origin.cdc.gov
... 0630 ANTIDEPRESSANTS 0631 ANOREXIANTS/CNS STIMULANTS 0632 CNS, MISCELLANEOUS 0633
ALZHEIMER-TYPE DEMENTIA 0634 SLEEP AID PRODUCTS (OTC) 0635 ANTIEMETICS ...
-

[PDF] NHANES 2001?2002 Data Documentation April 2005 SP Questionnaire Prescription Medication Subsection … -
DC Methods - origin.cdc.gov
... 0630 ANTIDEPRESSANTS 0631 ANOREXIANTS/CNS STIMULANTS 0632 CNS, MISCELLANEOUS 0633
ALZHEIMER-TYPE DEMENTIA 0634 SLEEP AID PRODUCTS (OTC) 0635 ANTIEMETICS ...
-

Viable contaminant particle free adenoviruses, their prepartion and use -
P Yeh, M Perricaudet, C Orsini - US Patent 6,312,946, 2001 - freepatentsonline.com
... dystrophy, cystic fibrosis, and the like), neurodegenerative diseases (Alzheimer's,
Parkinson's, ALS ... the right-hand end of the Ad5 genome up to position 34700. ...

Thiol proteases: inhibitors and potential therapeutic targets -
R Leung-Toung, Y Zhao, W Li, TF Tam, K Karimian, M … - Curr Med Chem, 2006 - ingentaconnect.com
Page 1. Current Medicinal Chemistry, 2006, 13, 547-581 547 0929-8673/06
$50.00+.00 ? 2006 Bentham Science Publishers Ltd. Thiol ...

[CITATION] 13.30 Xavier S?nchez: Presentaci? ?rea I+ D
DH DEL NIVELL PLASM?TIC
-

Cells for the production of recombinant adenoviruses -
US Patent 6,127,175, 2000 - freepatentsonline.com
... whose 5' end is between nucleotides 34360 and 34700 of the ... dystrophy, cystic fibrosis
and the like), neurodegenerative diseases (Alzheimer, Parkinson, ALS and ...

[PDF] MOLECULAR MECHANISM OF THE Ca 2-DEPENDENT ACTIVATION OF SORCIN (SOLUBLE RESISTANCE-RELATED CALCIUM …
M MELLA, DG COORDINATORE - padis.uniroma1.it
Page 1. MOLECULAR MECHANISM OF THE Ca 2+ -DEPENDENT ACTIVATION OF SORCIN
(SOLUBLE RESISTANCE- RELATED CALCIUM BINDING PROTEIN). A ...
-

Source: Google Scholar
 
 

Millions Of People Worldwide Suffer From Alzheimer's - Number Of Cases Feared To Double In Coming Years

 

 
A hundred years ago, the psychiatrist and brain researcher described the first patient with a severe dementia accompanied by the massive loss of nerve cells (neurons). At that time, the disease later named after him was still rare. Alzheimer saw only two cases in his research career, as Dr. Christian Haass, Professor at the Ludwig Maximilian University Munich, Germany, said during the International Conference on Neurodegenerative Diseases held in the Max Delbrück Communications Center (MDC.C) in Berlin.

Today, according to Dr. Haass, alone in Germany approximately 1.2 million people suffer from Alzheimer's disease. In the European Union, there are around 5 million people with dementia, of whom 60 - 70 percent are Alzheimer's patients. Around 4.5 million Alzheimer's patients live in the United States.

With people's life expectancy rising, scientists fear that the number of dementia and Alzheimer's patients will double in the next 25 years if the disease cannot be successfully treated or prevented. In 1985, scientists were able to identify the insoluble deposits in the brain as amyloid-beta plaques. In recent years, scientists have gained increasing insight into the molecular mechanisms of Alzheimer's disease which they hope will provide attack points for a targeted, causative treatment of this presently incurable disease.

The severe degenerative disorder of the brain in which people slowly lose their memory, their spatial orientation, their language, and the control over their body functions brings great suffering to Alzheimer's victims and their families, who often care for the patients for years. The cost of providing care for Alzheimer's patients is spiraling to billions of euros and dollars for the healthcare systems.

Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch
http://www.mdc
 
 
 
Google
Web www.iconocast.com
 
 
 

 

Continue News With: News2 ; News3 ; News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 © 2002-2006

Keywords::

Contact Iconocast

Home Page